Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Unlike corticosteroid injections (which reduce pain short-term but damage cartilage long-term), BPC-157 appears to be cartilage-sparing and potentially cartilage-supportive making it relevant for early-stage osteoarthritis or post-injury joint degradation
5 Star 260+ Google Reviews Address 2579 W
The peptides discussed here are not approved by the FDA for the uses described, and nothing on this page is a recommendation to obtain, self-administer, or dose them
BPC-157 + TB-500 Combination Peptide: The Ultimate Duo for Healing, Recovery, and Regeneration Modern medicine continues to evolve, and nowhere is this more evident than in the world of peptide therapy
WADA Prohibition The World Anti-Doping Agency classifies both peptides as prohibited substances: Both listed under Section S0 (Non-Approved Substances) Prohibited at all times (in and out of competition) No Therapeutic Use Exemptions (TUEs) available for either peptide Detection methods under development for anti-doping testing TB-500 and thymosin beta-4 explicitly banned since 2011 WADAs position reflects that neither peptide has regulatory approval from any health authority worldwide
/assets/images/provider/photos/2636389.jpg)
